← All Macrogenics INC filings

Macrogenics INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
MGNX
Macrogenics INC
DEF: MacroGenics Sets May 19th Annual Meeting, Proposes Equity Plan Boost
MacroGenics, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for May 19th, to elect directors and vote on an amendment to increase its 2023 Equity Incentive Plan shares.
NASDAQ
MGNX
Macrogenics INC
DEFA14A: Macrogenics, Inc. Files Definitive Proxy Statement
Macrogenics, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
MGNX
Macrogenics INC
DEF: MacroGenics Seeks Stockholder Approval for Equity Incentive Plan Amendment
MacroGenics is asking stockholders to approve an amendment to its 2023 Equity Incentive Plan to increase the number of shares available for issuance by 1,250,000.
NASDAQ
MGNX
Macrogenics INC
DEFA14A: Macrogenics, Inc. Files Definitive Proxy Statement with SEC
Macrogenics, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) regarding its upcoming shareholder meeting.
NASDAQ
MGNX
Macrogenics INC
DEF 14A: MacroGenics Seeks Stockholder Approval for Equity Incentive Plan Amendment
MacroGenics is asking stockholders to approve an amendment to its 2023 Equity Incentive Plan to increase the number of shares available for issuance by 2,000,000.